|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 EUR | -1.23% |
|
-1.64% | -21.31% |
| May. 21 | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
| May. 21 | Medigene AG's Global Research & Collaboration Agreement with BioNTech SE to Extend Beyond Initial Announced Term | CI |
Medigene AG maintained earnings guidance for 2024. For the year, company expects revenue to be between EUR 9 Million and 11 Million (unchanged) in 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.31% | 38.84M | |
| +11.91% | 114B | |
| +11.60% | 105B | |
| -4.68% | 23.83B | |
| -0.82% | 21.73B | |
| -10.12% | 18.1B | |
| -42.12% | 16.34B | |
| -17.47% | 16.13B | |
| +2.77% | 13.75B | |
| +34.58% | 11.76B |
MEDIGENE AG 
